BCAL Diagnostics

BCAL Diagnostics CROIC

The Cash Return on Invested Capital (CROIC) of BCAL Diagnostics (BDX.AX) as of Oct 17, 2026 is -80.51 %. In the previous year, Cash Return on Invested Capital (CROIC) was -56.11 % — a change of 43.48% (lower).

CROIC

-80.51 %

YoY

43.48%

Last updated:

Cash Return on Invested Capital (CROIC) of BCAL Diagnostics is 2025 -80.51 % . Cash Return on Invested Capital (CROIC) of BCAL Diagnostics was 2024 -56.11 % . It decreases by 43.48% lower compared to the previous year.

The BCAL Diagnostics CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
-115.95 AUD
Jan 1, 2019
-109.07 AUD
Jan 1, 2020
-90.07 AUD
Jan 1, 2021
-33.56 AUD
Jan 1, 2022
-33.66 AUD
Jan 1, 2023
-102.16 AUD
Jan 1, 2024
-56.11 AUD
Jan 1, 2025
-80.51 AUD
The BCAL Diagnostics CROIC history
YEARCROICYoY
-80.51 %+43.48%
-56.11 %-45.07%
-102.16 %+203.47%
-33.66 %+0.32%
-33.56 %-62.74%
-90.07 %-17.43%
-109.07 %-5.93%
-115.95 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BCAL Diagnostics Stock analysis

What does BCAL Diagnostics do? BCAL Diagnostics Ltd, based in Sydney, Australia, operates in the Health Care sector within the Biotechnology industry. The company develops innovative blood screening tests for early breast cancer detection, focusing on a lipid biomarker-based approach known as the BCAL test. This technology complements existing imaging methods like mammograms and aims to support screening and monitoring for women of all ages and backgrounds. BCAL Diagnostics has partnered with Precion Inc. to advance clinical trials and regulatory approvals for its diagnostic solutions. BCAL Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BCAL Diagnostics stock

Cash Return on Invested Capital (CROIC) of BCAL Diagnostics is -80.51 % in 2025.

Cash Return on Invested Capital (CROIC) of BCAL Diagnostics changed from -56.11 % to -80.51 %, representing a 43.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) BCAL Diagnostics since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s BCAL Diagnostics with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — BCAL Diagnostics

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — BCAL Diagnostics